INSP
Price
$128.32
Change
-$2.40 (-1.84%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
6.35B
33 days until earnings call
RMD
Price
$256.89
Change
+$1.01 (+0.39%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
29.13B
28 days until earnings call
Interact to see
Advertisement

INSP vs RMD

Header iconINSP vs RMD Comparison
Open Charts INSP vs RMDBanner chart's image
Inspire Medical Systems
Price$128.32
Change-$2.40 (-1.84%)
VolumeN/A
Capitalization6.35B
ResMed
Price$256.89
Change+$1.01 (+0.39%)
VolumeN/A
Capitalization29.13B
INSP vs RMD Comparison Chart in %
Loading...
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSP vs. RMD commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSP is a Buy and RMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (INSP: $128.48 vs. RMD: $256.96)
Brand notoriety: INSP and RMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INSP: 55% vs. RMD: 47%
Market capitalization -- INSP: $6.35B vs. RMD: $29.13B
INSP [@Medical Specialties] is valued at $6.35B. RMD’s [@Medical Specialties] market capitalization is $29.13B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSP’s FA Score shows that 0 FA rating(s) are green whileRMD’s FA Score has 2 green FA rating(s).

  • INSP’s FA Score: 0 green, 5 red.
  • RMD’s FA Score: 2 green, 3 red.
According to our system of comparison, RMD is a better buy in the long-term than INSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSP’s TA Score shows that 6 TA indicator(s) are bullish while RMD’s TA Score has 4 bullish TA indicator(s).

  • INSP’s TA Score: 6 bullish, 2 bearish.
  • RMD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, INSP is a better buy in the short-term than RMD.

Price Growth

INSP (@Medical Specialties) experienced а -0.95% price change this week, while RMD (@Medical Specialties) price change was +0.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

INSP is expected to report earnings on Aug 05, 2025.

RMD is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($29.1B) has a higher market cap than INSP($6.35B). RMD YTD gains are higher at: 12.858 vs. INSP (-30.694). RMD has higher annual earnings (EBITDA): 1.43B vs. INSP (-17.06M). INSP has more cash in the bank: 460M vs. RMD (210M). INSP has less debt than RMD: INSP (24.8M) vs RMD (1.39B). RMD has higher revenues than INSP: RMD (4.5B) vs INSP (625M).
INSPRMDINSP / RMD
Capitalization6.35B29.1B22%
EBITDA-17.06M1.43B-1%
Gain YTD-30.69412.858-239%
P/E RatioN/A31.34-
Revenue625M4.5B14%
Total Cash460M210M219%
Total Debt24.8M1.39B2%
FUNDAMENTALS RATINGS
INSP vs RMD: Fundamental Ratings
INSP
RMD
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
8054
SMR RATING
1..100
6538
PRICE GROWTH RATING
1..100
8317
P/E GROWTH RATING
1..100
10059
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (19) in the Medical Specialties industry is somewhat better than the same rating for INSP (77). This means that RMD’s stock grew somewhat faster than INSP’s over the last 12 months.

RMD's Profit vs Risk Rating (54) in the Medical Specialties industry is in the same range as INSP (80). This means that RMD’s stock grew similarly to INSP’s over the last 12 months.

RMD's SMR Rating (38) in the Medical Specialties industry is in the same range as INSP (65). This means that RMD’s stock grew similarly to INSP’s over the last 12 months.

RMD's Price Growth Rating (17) in the Medical Specialties industry is significantly better than the same rating for INSP (83). This means that RMD’s stock grew significantly faster than INSP’s over the last 12 months.

RMD's P/E Growth Rating (59) in the Medical Specialties industry is somewhat better than the same rating for INSP (100). This means that RMD’s stock grew somewhat faster than INSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INSPRMD
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Bullish Trend 9 days ago
62%
Declines
ODDS (%)
Bearish Trend 8 days ago
75%
Bearish Trend 2 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCWFX71.940.41
+0.57%
American Funds SMALLCAP World F1
PAGLX44.94N/A
N/A
T. Rowe Price Global Growth Stock Adv
GVIRX17.66N/A
N/A
Goldman Sachs US Eq Div and Premium Inv
JMNSX16.06N/A
N/A
JPMorgan Research Market Neutral I
SPSDX18.25N/A
N/A
Sterling Capital Behav Sm Cp Val Eq C

INSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSP has been loosely correlated with TMCI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSP
1D Price
Change %
INSP100%
-1.71%
TMCI - INSP
54%
Loosely correlated
+1.48%
MASI - INSP
47%
Loosely correlated
-2.20%
VCYT - INSP
41%
Loosely correlated
-0.25%
RMD - INSP
34%
Loosely correlated
+0.42%
INGN - INSP
33%
Loosely correlated
+0.94%
More

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with RVTY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+0.42%
RVTY - RMD
43%
Loosely correlated
+0.41%
IDXX - RMD
41%
Loosely correlated
+0.79%
SYK - RMD
37%
Loosely correlated
+0.89%
LH - RMD
37%
Loosely correlated
+0.73%
BLCO - RMD
36%
Loosely correlated
+0.87%
More